Combinations of a VEGF receptor inhibitor with other therapeutic agents

Details for Australian Patent Application No. 2004273619 (hide)

Owner Novartis AG

Inventors Bold, Guido; Kinder, Frederick Ray; Latour, Elisabeth Jeanne; Manley, Paul William; Brueggen, Josef Bernhard; Wood, Jeanette Marjorie; Lane, Heidi; Huang, Jerry Min-Jian

Agent Davies Collison Cave

Pub. Number AU-A-2004273619

PCT Pub. Number WO2005/027973

Priority 60/505255 23.09.03 US

Filing date 23 September 2004

Wipo publication date 31 March 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/027973 Priority application(s): WO2005/027973

12 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273627-Compliance monitor and method

2004273618-Coated tablets